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To foster new ideas in the neurobiology of neuropsychiatric 
disorders, it is important to explore new hypothesis regarding the 
mechanisms of action of the candidate genes and to use appropri-
ate substrates to test them. The use of animal models – even con-
sidering the genetic variability due to background and  species – is 
critical to access the developmental brain, and to study the onset 
and progression of the disorders. Even if the clinical investigation 
in humans cannot be performed on the rodent models, there are 
parallel signs that can be used as endophenotypes, such as the 
reduction in the number of dendritic spines, deficits in working 
memory, and the structural and functional organization of the 
brain (Mothersill et al., 2012). Other clues can be found in brain 
areas rarely explored in neuropsychiatric disorders, such as the 
visual cortex. Recent evidence proved that synaptic reinforcement 
in evoked visual stimulation is hampered in patients with schizo-
phrenia (Cavus¸ et al., 2012). This is not surprising, considering 
that the majority of candidate genes for psychosis relate to the 
function of synapses, and that the candidate genes are mutated in 
all brain areas. Therefore, the visual cortex can be a valid model 
for investigating the role of candidate genes in circuitry function 
and plasticity both in vitro and in vivo, as shown in animal models 
of autism (Banerjee et al., 2012). Together with the exploration of 
new brain areas, new players should be taken into account, such 
as inhibitory circuitry (Chattopadhyaya and Di Cristo, 2012) and 
microRNAs (Mellios and Sur, 2012). Finally, because several genes 
are mutant in different conditions, we need to understand the 
overlapping developmental processes common to several disorders 
(Bozzi et al., 2012).
In conclusion, the deep understanding of neuropsychiatric 
disorders requires a combination of techniques, including genetic 
studies, animal models and imaging, and more than that, requires 
going beyond the hypothesis currently tested, and explore new 
mechanisms and endophenotypes. Only using this new, multidis-
ciplinary approach it will be possible to clarify the mechanisms 
involved in the onset and progression of neuropsychiatric disorders 
with the perspective of revealing the biological signs of the disorders 
and identifying new therapeutics.
RefeRences
Banerjee, A., Castro, J., and Sur, M. (2012). Rett syndrome: genes, synapses, circuits and 
therapeutics. Front. Psychiatry 3:34. doi: 10.3389/fpsyt.2012.00034
Bozzi, Y., Casarosa, S., and Caleo, M. (2012). Epilepsy as a neurodevelopmental disorder. 
Front Psychiatry 3:19. doi: 10.3389/fpsyt.2012.00019
Research in neuropsychiatric conditions is living a unique time: 
genomic analysis advanced the knowledge of the genetic causes of 
these disorders. At the same time technological advances make pos-
sible a deep investigation of the structure and function of the brain 
(Mothersill et al., 2012) and Induced Pluripotent Stem Cells (IPSC) 
technology gives us access to neuronal cultures from each single 
patient (Cheung et al., 2012). These progresses hold the promise 
for a better understanding of neuropsychiatric disorders with a 
consequent improvement in the tools for diagnosis and treatment.
Nonetheless, the more we deepen our understanding, the more 
the complexity appears, and this is due to several reasons: first, 
except for rare monogenic disorders, the majority of neuropsy-
chiatric conditions are polygenic. Second, the molecular etiology 
is complex: many of the same susceptibility genes and molecular 
pathways are emerging across hitherto unrelated disorders – such as 
autism and schizophrenia – challenging how we conceptualize these 
conditions (Mitchell, 2011). Third, genetic background interacts 
with environmental factors to produce the onset and progression 
of the disease (Stolp et al., 2012) with the consequence that genetic 
analysis alone cannot predict the outcome of specific clinical symp-
toms, and environmental factors are critical.
Despite recent advances in genetics and imaging, the neurobiol-
ogy of neuropsychiatric disorders remains largely obscure. Much 
of the evidence from genomics implicates molecular mechanisms 
of neurosynaptic development, plasticity, and function (Mitchell, 
2011), and research is converging on deficits in the function of neu-
ronal circuitry. As a consequence, we need to establish additional 
criteria for the classification of the genes and related phenotypes 
and new parameters should be taken into account such as the genet-
ics, the neurobiology of the gene products, and the molecular and 
physiological mechanisms that they control. This task requires a 
combination of approaches, including animal models and human 
studies.
In autism research, several steps have been undertaken in this 
direction and in some cases it has been possible to clarify the intra-
cellular pathways and to produce novel therapeutics (Banerjee et al., 
2012). This has been possible for monogenic disorders such as Rett 
syndrome, Angelmann syndrome, and Fragile X, thanks to the gen-
esis of animal models that present similar genetics and symptoms of 
the patients. However, this is just a minority of disorders as autism 
has a complex genetic background. Also for psychosis, research is 
slowly progressing toward the comprehension of the neurobiology 
of high penetrant variants in schizophrenia (Kamiya et al., 2012).
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